[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
Global Synthetic Biology Market
Healthcare Services

Synthetic Biology Market Growth Outlook Reveals A CAGR Of 18.2% And A Market Value Of $62.48 Billion By 2030

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Synthetic Biology Market Size, Value And Growth Trends Through 2030

The synthetic biology market experienced substantial growth, projected to expand from $26.63 billion in 2025 to $32 billion in 2026, reflecting a compound annual growth rate (CAGR) of 20.2% during this timeframe. Key drivers behind this upward trajectory in the preceding period included significant progress in genetic engineering methodologies, increased investment in both academic and industrial research endeavors, the heightened accessibility of sequencing technologies, the initial commercial rollout of synthetic organisms, and a strengthening of partnerships between academic institutions and commercial enterprises.

The synthetic biology sector is poised for substantial expansion, with projections indicating a market valuation of $62.48 billion by 2030, reflecting a compound annual growth rate (CAGR) of 18.2%. This anticipated surge is fueled by several key drivers, including augmented investments directed towards bio-manufacturing, a growing consumer and industrial demand for environmentally friendly chemicals and fuels, the broadening application of synthetic biology across the healthcare spectrum, the increasing incorporation of artificial intelligence in biological design processes, and a clearer regulatory landscape for genetically engineered organisms. Notable developments expected during this period involve the widespread adoption of CRISPR gene-editing technologies, a greater reliance on bioinformatics for design purposes, the scaling up of synthetic gene construction platforms, a heightened emphasis on sustainable bio-based manufacturing, and advancements in the automation of biological engineering processes.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2508&type=smp

Synthetic Biology Market Demand Drivers Creating New Revenue Opportunities

The synthetic biology market is poised for expansion, largely fueled by escalating investments in research and development. Recognizing the critical role of R&D, which involves systematic investigation and innovation to generate novel knowledge, technologies, and products, companies are channeling more resources into this area. This surge in R&D funding is a direct response to heightened competition, a persistent demand for innovative solutions, rapid technological progress, and the necessity for businesses to remain agile amidst evolving consumer tastes and market conditions. Synthetic biology’s potential to engineer biological systems for specific applications, thereby offering sustainable solutions in domains like healthcare, agriculture, and environmental stewardship, hinges on robust R&D endeavors. Illustrating this trend, the UK’s net expenditure on R&D reached £17.4 billion ($22.1 billion) in 2023, an increase from the £16.1 billion ($20.45 billion) recorded in 2022, signifying an 8.2% uptick, as reported by the Office for National Statistics. Consequently, this heightened commitment to research and development is a primary catalyst for the synthetic biology sector’s growth.

Synthetic Biology Market Segmentation: How Is The Market Structured Across Key Categories?

The synthetic biology market covered in this report is segmented –

1) By Technology: Nucleotide Synthesis And Sequencing, Bioinformatics, Microfluidics, Genetic Engineering

2) By Product Type: Oligonucleotides, Enzymes, Cloning And Assembly Kits, Xeno-Nucleic Acids (XNA), Chassis Organism

3) By Application: Pharmaceuticals And Diagnostics, Chemicals, Biofuels, Bioplastics, Other Application

Subsegments:

1) By Nucleotide Synthesis And Sequencing: DNA Synthesis Technologies, Next-Generation Sequencing (NGS), Sanger Sequencing

2) By Bioinformatics: Software Tools For Genomic Data Analysis, Databases For Gene/Protein Information, Algorithms For Gene Editing And Design

3) By Microfluidics: Lab-On-A-Chip Technologies, Microfluidic Devices For Biological Assays, Applications In Drug Discovery And Diagnostics

4) By Genetic Engineering: CRISPR/Cas9 Technology, Recombinant DNA Technology, Synthetic Gene Construction And Assembly

Synthetic Biology Market Trends Driving Strategic Industry Expansion

Leading entities within the synthetic biology sector are concentrating their efforts on pioneering novel offerings, exemplified by bespoke service packages designed to streamline the design-build-test phases, thereby expediting customized synthetic biology endeavors. These individualized service arrangements afford clients the opportunity to collaborate directly with specialized professionals for the creation, construction, and validation of synthetic DNA sequences, moving beyond the limitations of pre-existing inventory. A notable illustration occurred in June of 2025 when Integrated DNA Technologies (IDT), a biotechnology firm headquartered in the United States, introduced its Synthetic Biology Custom Solutions Program. This premium manufacturing provision grants clientele direct engagement with IDT’s internal scientific and engineering personnel to undertake bespoke projects, encompassing everything from intricate gene sequences to atypical DNA segments. Prominent characteristics encompass a devoted team to facilitate design-build-test methodologies, bespoke production capabilities within IDT’s extensive 25,000-square-foot synthetic biology facility, broad acceptance of diverse project scopes (including but not limited to high-efficiency non-standard gene fragments, genes exceeding 5 kilobases, and multi-site cloning techniques), and accelerated project completion by eliminating stringent high-throughput limitations. Ultimately, this initiative equips advancements and innovators in synthetic biology with the ability to accelerate their iterative processes and surmount obstacles within their research and development pipelines.

Synthetic Biology Market Competitive Landscape And Leading Companies

Major companies operating in the synthetic biology market are Thermo Fisher Scientific Inc, Danaher Corporation, Eurofins Scientific, Merck KGaA, Novozymes A/S, Agilent Technologies, New England Biolabs Inc, Precigen Inc, Amyris, Inc, Genscript Biotech Corporation, Codex Genetics, Cathay Biotech, Bota Biosciences, Bluepha, Spiber, OriCiro Genomics Inc, Provectus Algae, Puraffinity, Royal DSM NV, Colorifix, Phytoform Labs, Desktop Genetics, NanoSyrinx, Pulmobiotics S.L, EnginZyme, Chain Biotech, Nuclera Nucleics, Biosynthetics GmbH, Entelechon GmbH, Sloning BioTechnology GmbH, Prokarium Ltd, Synbio, Captor Therapeutics, Gero.ai, ARNA Genomics, Solvo Omixon, Soft flow, Algenol, Genomatica, Integrated DNA Technologies, Sana Biotechnology, Impossible Foods, Apeel Sciences, Twist Bioscience, Synlogic, Zymergen Inc, Ginkgo Bioworks, Codexis, Arzeda Corporation, Synthetic Genomics, Conagen, Dupont, Oxitec Ltd, Sentebiolab, GEEN Biotechnology Inc, Genbiotek Biosistem Laboratory Ltd

Access The Complete Synthetic Biology Market Report:

https://www.thebusinessresearchcompany.com/report/synthetic-biology-global-market-report

Synthetic Biology Market Geographic Landscape: Which Region Dominates Industry Growth?

North Americawas the largest region in the synthetic biology market in 2025. Western Europewas the second largest region in the global synthetic biology market share. The regions covered in the synthetic biology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong. [KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.